Breaking News, Promotions & Moves

Basking Biosciences Names Dr. Julia Owens as CEO

Owens brings extensive leadership experience in biopharmaceutical company building and drug development.

Author Image

By: Charlie Sternberg

Associate Editor

Julia C. Owens, Ph.D.

Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic stroke (AIS), has appointed Julia C. Owens, Ph.D., as Chief Executive Officer (CEO). Owens brings extensive leadership experience in biopharmaceutical company building and drug development, having served as CEO of Ananke Therapeutics and founder and CEO of Millendo Therapeutics. She has held board roles at both emerging and publicly traded companies and curre...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters